• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN KANGAROO EPUMP - NEW; PUMP, INFUSION, ENTERAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN KANGAROO EPUMP - NEW; PUMP, INFUSION, ENTERAL Back to Search Results
Model Number 382400
Medical Device Problem Code Excess Flow or Over-Infusion (1311)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The pump s/n: (b)(4) was not returned by the customer for evaluation.No further testing could be performed.Complaint trending information is being reviewed on a monthly basis and if a trend is observed, actions will be taken as necessary.
 
Event or Problem Description
The customer reported that the device had over the limit error upon testing.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
KANGAROO EPUMP - NEW
Common Device Name
PUMP, INFUSION, ENTERAL
Manufacturer (Section D)
COVIDIEN
15 hampshire street
mansfield MA 02048
MDR Report Key12072949
Report Number1282497-2021-10463
Device Sequence Number3674912
Product Code LZH
UDI-Device Identifier10884521006614
UDI-Public10884521006614
Combination Product (Y/N)N
Initial Reporter StateMS
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,user f
Initial Reporter Occupation Other
Type of Report Initial
Report Date (Section B) 06/26/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device No Information
Device Model Number382400
Device Catalogue Number382400
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 08/31/2020
Initial Report FDA Received Date06/26/2021
Patient Sequence Number1
-
-